Drs Katrina Bramstedt and Ana Iltis discuss the development of QoL assessment tools to help patient-subjects considering reconstructive transplantation.

Dr Helen Stanton Chapple joins Ethics Talk to discuss her article: "Solidarity in Mortal Time.”

Grayson Holt joins Ethics Talk to discuss his article, coauthored with Dr Johanna Glaser: “Why Is Hospice One of the Few Health Care Environments Structured for Peace?”

The experience of an English professor dying of ovarian cancer in Margaret Edson’s play Wit shows that both literary and medical discourse obfuscate and objectify rather than promote communication of “simple human truths” that dignify life and death.

Physicians’ ethical obligations to disclose conflicts of interest to patients and to obtain their informed consent for treatment are particularly critical when proposed treatments are experimental.

Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients.

The authors of a recent journal article believe that most doctors and clinical trial sponsors would not object to changes in regulations requiring doctors to disclose financial incentives to their patients.

Protecting patients rather than informed consent should be the goal when the complexity of information overwhelms patients’ decision-making capacity.

A historical look at dermatological testing and the regulations that have been enacted to protect the patients who test skin care products.